May 20 (Reuters) - German vaccine maker BioNTech , opens new tab said on Tuesday that it plans to expand its investment in the United Kingdom by up to 1 billion pounds ($1.33 billion) over the ...

Roughly five months after AstraZeneca scrapped a major investment plan in its home country, the United Kingdom has found a fresh partner in mRNA specialist BioNTech. BioNTech plans to invest up to ...

MAINZ, Germany, September 17, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech”), alongside its artificial intelligence (“AI”) company InstaDeep Ltd. (“InstaDeep”), will ...

The United Kingdom has signed a deal with German pharmaceutical company BioNTech They hope to provide personalised cancer therapies for up to 10,000 patients by the end of 2030 ...

German vaccine maker BioNTech said on Tuesday that it plans to expand its investment in the United Kingdom by up to 1 billion pounds ($1.33 billion) over the next ten years to broaden its research ...

While Pfizer’s German mRNA partner BioNTech has high ... launched a variant-adapted version of its shot in the European Union and received approval for the same vaccine in the United Kingdom.

MAINZ, Germany, and LONDON, United Kingdom, January 10, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech”) and InstaDeep Ltd. (“InstaDeep”) today announced that they have entered into an agreement under ...

BioNTech has signed an agreement with British authorities over the commencement of mRNA vaccine trials in the United Kingdom. This could lead to the advancement of personalized cancer immunotherapies.

As BioNTech continues to endure a sharp decline in COVID-19 vaccine sales, ... BioNTech also expects new private markets to open up in places like the United Kingdom this year, Richardson noted.

Standard Group Plc HQ Office, The Standard Group Center,Mombasa Road. P.O Box 30080-00100,Nairobi, Kenya. Telephone number: 0203222111, 0719012111 ...

The company said its subsidiary BioNTech UK signed a grant agreement with the UK government that builds on a multi-year collaboration announced in January 2023. Under the deal, BioNTech had undertaken ...